Shay Capital’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$308K Buy
50,229
+6,330
+14% +$52.7K 0.03% 336
2025
Q4
$365K Buy
43,899
+22,701
+107% +$244K 0.04% 333
2025
Q3
$309K Buy
21,198
+1,816
+9% +$21.7K 0.03% 303
2025
Q2
$218K Buy
19,382
+1,124
+6% +$8.71K 0.03% 250
2025
Q1
$104K Sell
18,258
-4,411
-19% -$44.9K 0.02% 270
2024
Q4
$223K Buy
+22,669
New +$194K 0.03% 248
2024
Q3
Sell
-3,331
Closed -$44.5K 355
2024
Q2
$44.5K Buy
3,331
+2,224
+201% +$66.4K 0.01% 249
2024
Q1
$51.4K Buy
1,107
+431
+64% +$22.3K 0.01% 351
2023
Q4
$45.7K Hold
676
0.01% 252
2023
Q3
$49K Sell
676
-55
-8% -$4.4K 0.01% 313
2023
Q2
$54.4K Hold
731
0.01% 361
2023
Q1
$38.9K Buy
731
+376
+106% +$23.8K 0.01% 384
2022
Q4
$24K Buy
+355
New +$32.7K 0.01% 255
2022
Q3
Sell
-301
Closed -$29K 391
2022
Q2
$29K Buy
+301
New +$36.7K 0.01% 384

Other funds holding DNA